Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Radiosurgery × Clear all

NCT04767009 2025-04-30

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01753414 2025-01-06

POSTILV

Phase 2 Unknown

44 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05259319 2023-10-17

IMMUNOs-SBRT

Phase 1 Unknown

GenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT05451173 2023-10-03

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05737589 2023-02-21

Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04758481 2022-12-07

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05577052 2022-10-13

SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05472467 2022-07-25

IMCORT-2

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01711697 2021-06-23

An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00643318 2021-03-05

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04255836 2020-02-05

Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01795521 2020-01-31

LungTech

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04106180 2019-09-26

SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02759783 2019-08-21

CORE

Phase 2/3 Unknown

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT03446911 2018-02-27

Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02568033 2017-01-31

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02584699 2015-10-23

Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01920789 2014-12-09

SPACE

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT01301560 2011-02-23

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01130766 2010-05-26

Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung